摘要
前列腺癌是男性最常见的肿瘤之一，发病率高，其中去势抵抗性前列腺癌（CRPC）治疗棘手，预后欠佳，随着对其发病机制研究的深入，近年已有新的治疗手段出现，为治疗CRPC带来新的希望。
Prostate cancer represents one of the most common cancer in men, and the treatment of castrate refractory prostate cancer （CRPC） is still a challenge in the clinical practice, as there are few effective therapies to lengthen patients life. Nowadays, with the expansion of knowledge regarding the biology of CRPC, many novel approaches which are currently in development yielded promising results in the clinical setting for patients.
出处
《肿瘤研究与临床》
CAS
2012年第4期282-285,共4页
Cancer Research and Clinic
关键词
前列腺肿瘤
雄激素拮抗药
免疫疗法
受体
内皮素A
治疗结果
Prostatic neoplasms
Androgen antagonists
Immunotherapy
Reaptor, endothelin A
Treatment outcome
